Coverage
-
May 26, 2015
The plaintiffs' steering committee in the multidistrict litigation against Pfizer over its alleged illegal marketing of Neurontin for off-label use told a Massachusetts federal judge Friday that Bernstein Liebhard is seeking more money than it legally deserves.
14 other articles on this case.
View all »